Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Bioventus

Bioventus (NASDAQ: BVS) insider transactions

In the twelve months to 10 November 2026, executives and directors of Bioventus reported 2 open-market sales of 22,000 shares ($181,180) and 0 open-market purchases, by 2 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Bioventus shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
2 June 2026Sutter Martin PDirectorOption exercise+32,282—117,523Form 4
2 June 2026Hawkins William ADirectorOption exercise+39,789—297,640Form 4
2 June 2026Nohra Guy PDirectorOption exercise+32,282—148,892Form 4
2 June 2026Stalnecker Susan MDirectorOption exercise+32,282—138,239Form 4
2 June 2026Neels Guido JDirectorOption exercise+32,282—117,523Form 4
2 June 2026Bartholdson John A.DirectorOption exercise+32,282—111,902Form 4
2 June 2026Beyer PatDirectorOption exercise+32,282—108,718Form 4
2 June 2026Cowdy Philip G.DirectorOption exercise+32,282—43,982Form 4
2 June 2026Ladone Mary KayDirectorOption exercise+32,282—111,263Form 4
2 June 2026McMurry-Heath MichelleDirectorOption exercise+32,282—77,279Form 4
10 April 2026Church Katrina JSVP & Chief Compliance OfficerOption exercise+4,300—66,032Form 4
10 April 2026Church Katrina JSVP & Chief Compliance OfficerShares withheld for tax−1,868$9.0664,164Form 4
10 April 2026D'Adamio AnthonySVP & General CounselOption exercise+9,925—157,967Form 4
10 April 2026D'Adamio AnthonySVP & General CounselShares withheld for tax−4,312$9.06153,655Form 4
10 April 2026Singleton Mark LeonardSVP & CFOOption exercise+13,000—182,981Form 4
10 April 2026Singleton Mark LeonardSVP & CFOShares withheld for tax−5,648$9.06177,333Form 4
20 March 2026Singleton Mark LeonardSVP & CFOOption exercise+18,625—178,072Form 4
20 March 2026Singleton Mark LeonardSVP & CFOShares withheld for tax−8,091$8.64169,981Form 4
13 March 2026Church Katrina JSVP & Chief Compliance OfficerOption exercise+3,455—61,254Form 4
13 March 2026Church Katrina JSVP & Chief Compliance OfficerShares withheld for tax−1,501$8.6259,753Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Bioventus page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.